Related references
Note: Only part of the references are listed.Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions
Do-Sim Park et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Omar Khan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway
K. F. Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin
Lei Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Survivin regulation by HER2 through NF-κB and c-myc in irradiated breast cancer cells
Vassilis Papanikolaou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Regulation of survivin by PI3K/Akt/p70S6K1 pathway
Peng Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
Kamil Gotfryd et al.
BMC CANCER (2010)
Neuroblastoma: Biology, Prognosis, and Treatment
Julie R. Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
F. Condorelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
Alfonso Duenas-Gonzalez et al.
CANCER TREATMENT REVIEWS (2008)
Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
Annick Muehlethaler-Mottet et al.
MOLECULAR CANCER (2008)
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Marielle Dejligbjerg et al.
MOLECULAR CANCER (2008)
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Aleksey G. Kazantsev et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Histone deacetylases: target enzymes for cancer therapy
Denis Mottet et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application
V. Santini et al.
CURRENT DRUG METABOLISM (2007)
Histone deacetylase inhibitors in cancer therapy
Walid K. Rasheed et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells
Alessandra Valentini et al.
CANCER BIOLOGY & THERAPY (2007)
Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B
Jihong Chen et al.
MOLECULAR CANCER (2006)
Aberrant regulation of survivin by the RB/E2F family of proteins
YY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis
A Chandele et al.
NEOPLASIA (2004)
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
A Mirza et al.
ONCOGENE (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma
T Azuhata et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mechanisms of action of valproate: a commentatory
CU Johannessen
NEUROCHEMISTRY INTERNATIONAL (2000)
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study
ML Schmidt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
